Romiplostim Treatment of Thrombocytopenia in Subjects With Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

This study has been terminated.

( Please see detailed description under Purpose )

Study NCT00614523 Information provided by Amgen

First Received: January 31, 2008 Last Updated: December 15, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Estimated Study Completion Date:	March 2016
Primary Completion Date:	April 2011 (Final data collection date for primary outcome measure)